The influence of metronidazole (MET) resistance on the efficacy of two triple therapy regimens with ranitidine bismuth citrate (RBC) for H-pylori (Hp) infection

被引：0
|
作者：
Van der Wouden, EJ
Thijs, JC
van Zwet, AA
Kooy, A
Kleibeuker, JH
机构：
[1] Univ Groningen Hosp, Groningen, Netherlands
[2] Bethesda Hosp, Hoogeven, Netherlands
来源：
GUT | 1998年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A86 / A86
页数：1
相关论文
共 50 条
  • [41] One-week therapy with omeprazole (PPI) or ranitidine bismuth citrate (RBC) and two antibiotics for eradication of H-pylori in duodenal ulcer (DU): Interim report of a multicentre study
    Spinzi, G
    Boni, F
    Ballardini, G
    Prada, A
    Venturelli, R
    Minoli, G
    GASTROENTEROLOGY, 1999, 116 (04) : A317 - A317
  • [42] Ranitidine bismuth citrate (RBC) based triple therapy for 7 days is more effective than RBC plus clarithromycin for 14 days in dyspeptic patients with Helicobacter pylori infection
    Cestari, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (10) : 991 - 996
  • [43] Levofloxacin-vs. ranitidine bismuth citrate-containing therapy after H-pylori treatment failure
    Gisbert, Javier P.
    Gisbert, Jose Luis
    Marcos, Santiago
    Moreno-Otero, Ricardo
    Pajares, Jose Maria
    HELICOBACTER, 2007, 12 (01) : 68 - 73
  • [44] Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment:: a pilot study
    Calvet, X
    Montserrat, A
    Güell, M
    Vergara, M
    Gené, E
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2004, 16 (10) : 987 - 990
  • [45] One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance
    Wong, BCY
    Wong, WM
    Wang, WH
    Fung, FMY
    Lai, KC
    Chu, KM
    Yuen, ST
    Leung, SY
    Hu, WHC
    Yuen, MF
    Lau, GKK
    Chan, CK
    Lam, SK
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (03) : 403 - 409
  • [46] One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection:: the RBC-MACH study
    Sung, JJY
    Chan, FKL
    Wu, JCY
    Leung, WK
    Suen, R
    Ling, TKW
    Lee, YT
    Cheng, AFB
    Chung, SCS
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (08) : 1079 - 1084
  • [47] Ranitidine bismuth citrate with low-dose clarithromycin and metronidazole for one week gives high rates of H-pylori eradication.
    Wetterhus, S
    Boixeda, D
    Altorjay, I
    Federico, R
    Vanweerts, S
    Duggan, AE
    GASTROENTEROLOGY, 1998, 114 (04) : A330 - A330
  • [48] One-week ranitidine bismuth citrate-based low dose clarithromycin triple therapy is superior to omeprazole-based regime for the eradication of Helicobacter pylori (H-pylori) in Hong Kong with high prevalence of metronidazole resistance.
    Wong, WM
    Wong, B
    Wang, W
    Chu, K
    Lai, K
    Hu, W
    Fung, F
    Yeun, MF
    Lau, G
    Chan, C
    Lai, C
    Lam, S
    GASTROENTEROLOGY, 2000, 118 (04) : A503 - A503
  • [49] Evaluation of Two Triple-Therapy Regimens with Metronidazole or Clarithromycin for the Eradication of H-pylori Infection in Vietnamese Children: a Randomized, Double-Blind Clinical Trial
    Nguyen, Thi Viet Ha
    Bengtsson, Carina
    Nguyen, Gia Khanh
    Hoang, Thi Thu Ha
    Phung, Dac Cam
    Sorberg, Mikael
    Granstrom, Marta
    HELICOBACTER, 2008, 13 (06) : 550 - 556
  • [50] One-week ranitidine bismuth citrate (RBC) triple therapy versus proton-pump inhibitor (PPI) triple therapy for the treatment of H-pylori-associated duodenal ulcers
    Sung, JY
    Leung, WK
    Ling, TKW
    Yung, MY
    Chan, KL
    Lee, YT
    Chung, SCS
    Cheng, AFB
    GUT, 1997, 41 : A51 - A52
12345